Skip to main content

Advertisement

Table 3 Outcomes in patients with or without autoimmune rheumatic disease who experienced a first myocardial infarction between 1 July 2001 and 30 June 2007 a

From: Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease

Variable Non-AIRD (nā€‰=ā€‰77,981) AIRD (nā€‰=ā€‰1,409) Crude OR (95% CI) Adjusted OR b (95% CI)
30-day mortality, all cause 10,452 (13.4) 301 (21.4) 1.76 (1.54 to 2.00) 1.44 (1.26 to 1.65)
30-day mortality, cardiovascular 9,105 (11.7) 266 (18.9) 1.76 (1.54 to 2.02) 1.44 (1.25 to 1.66)
12-month mortality, all cause 17,766 (22.8) 544 (38.6) 2.13 (1.91 to 2.38) 1.82 (1.61 to 2.05)
12-month mortality, cardiovascular 15,095 (19.4) 464 (32.9) 2.05 (1.83 to 2.29) 1.71 (1.51 to 1.94)
  1. aAIRD, Autoimmune rheumatic disease; OR, Odds ratio. bAdjusted for age, sex, Accessibility/Remoteness Index of Australia, Socio-Economic Indexes for Areas and comorbidities.